MedTrace Logo

Short-course Preoperative Chemoradiotherapy for Rectal Cancer

NCT01431599 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2017-10-10

No results posted yet for this study

Summary

The purpose of this study is to evaluate the early clinical outcome of the short-course preoperative chemoradiotherapy, 33Gy/10 fx and delayed operation after chemoradiation, the investigators initiated the clinical trial of KROG 11-02.

Conditions

Interventions

RADIATION

short-course radiation

33Gy/10 fractions

Sponsors & Collaborators

  • Seoul National University Hospital

    collaborator OTHER

  • Samsung Medical Center

    collaborator OTHER

  • National Cancer Center, Korea

    collaborator OTHER_GOV

  • Jong Hoon Lee

    lead OTHER

Principal Investigators

  • Hong Seok Jang, MD · Department fo Radiation Oncology, Seoul St. Mary's Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2012-10-31
Completion
2017-10-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01431599 on ClinicalTrials.gov